Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Durect Corp (DRRX)  
$1.06 0.07 (6.19%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 22,790,000
Market Cap: 24.16(M)
Last Volume: 563,483 Avg Vol: 252,607
52 Week Range: $0.502 - $7
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Durect is a biopharmaceutical company developing therapies derived from its Epigenetic Regulator Program. Larsucosterol (also known as DUR-928), a chemical entity in clinical development, is the primary candidate in Co.'s Epigenetic Regulator Program. A bioavailable small molecule, larsucosterol has been shown in both in vitro and in vivo studies to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival. Co. is conducting a double-blind, placebo-controlled Phase 2b clinical trial called AHFIRM, in which Co. is evaluating larsucosterol's life saving potential in patients with severe alcohol-associated hepatitis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 482,093
Total Buy Value $0 $0 $0 $288,249
Total People Bought 0 0 0 4
Total Buy Transactions 0 0 0 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 152
  Page 3 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Theeuwes Felix Chairman and CSO   •       •      –    2016-04-26 4 B $1.25 $200,000 I/I 160,000 3,396,314 2.66     -
   Hoffmann Dave Director   –       •      –    2016-04-26 4 B $1.25 $250,000 I/I 200,000 248,000 2.1     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2016-04-26 4 B $1.25 $6,875,000 D/D 5,500,000 19,881,546 2.45     -
   Theeuwes Felix Chairman and CSO   •       •      –    2016-03-14 4 B $1.41 $98,950 I/I 70,000 3,236,314 2.66     -
   Blaschke Terrence F Director   –       •      –    2016-03-14 4 B $1.35 $4,050 I/I 3,000 3,000 2.1     -
   Neukernons Arnand Director   –       •      –    2016-03-14 4 B $1.39 $25,032 I/I 18,000 38,000 2.1     -
   Brown James E President & CEO   •       •      –    2016-03-10 4 B $1.30 $26,564 I/I 20,000 70,000 2.66     -
   First Eagle Value In Biotechnology Master Fund, Lt 10% Owner   –       –       •   2016-01-11 4 B $1.37 $410,537 D/D 300,100 14,381,546 2.45     -
   First Eagle Value In Biotechnology Master Fund, Lt 10% Owner   –       –       •   2015-09-29 4 B $1.80 $1,593,088 D/D 885,049 14,081,446 2.45     -
   Neukernons Arnand Director   –       •      –    2015-05-22 4 B $2.39 $48,096 I/I 20,000 20,000 2.1     -
   First Eagle Value In Biotechnology Master Fund, Lt 10% Owner   –       –       •   2015-03-17 4 B $1.59 $106,848 D/D 67,200 13,196,397 2.45     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2015-03-16 4 B $1.66 $166,000 D/D 100,000 13,129,397 2.45     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2015-03-13 4 B $1.66 $280,208 D/D 168,800 13,029,197 2.45     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2015-03-12 4 B $1.69 $338,000 D/D 200,000 12,860,397 2.45     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2015-03-11 4 B $1.69 $676,000 D/D 400,000 12,660,397 2.45     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2015-03-10 4 B $1.74 $870,000 D/D 500,000 12,260,397 2.45     -
   Benito Simon X Director   –       •      –    2015-03-10 4 B $1.81 $72,260 D/D 40,000 60,000 2.39     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2015-03-09 4 B $1.69 $507,000 D/D 300,000 11,760,397 2.45     -
   Arnhold & S. Bleichroeder Holdings, Inc. 10% Owner   –       –       •   2015-03-09 3 IO $0.00 $0 D/D 0 11,460,397     -
   Theeuwes Felix Chairman and CSO   •       •      –    2015-03-09 4 B $1.62 $371,747 I/I 225,600 3,166,314 2.66     -
   Theeuwes Felix Chairman and CSO   •       •      –    2015-03-06 4 B $1.41 $595,932 I/I 380,000 2,940,714 2.66     -
   Theeuwes Felix Chairman and CSO   •       •      –    2014-11-21 4 B $1.00 $72,700 I/I 72,700 2,560,714 2.66     -
   Theeuwes Felix Chairman and CSO   •       •      –    2014-11-20 4 B $0.92 $46,943 I/I 49,603 2,488,014 2.66     -
   Theeuwes Felix Chairman and CSO   •       •      –    2014-11-19 4 B $0.88 $77,705 I/I 86,412 2,438,411 2.66     -
   Joice Judy R Sr. VP Operations & Corp QAOff   •       –      –    2014-03-28 3 IO $0.00 $0 D/D 0 11,104     -
  152 Records found
  1  2  3  4  5  6  7   
  Page 3 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us